sustain 6 trial semaglutide 🔑 SUSTAIN-6 (NEJM 2016) — the safety that became a landmark., In 3,297 patients with type 2 diabetes at high CV risk, reduced:, • 3-point MACE 26% (HR 0.74), • Nonfatal stroke 39% Semaglutide and Cardiovascular Outcomes in

Summary of Product Characteristics (Forxiga)

Propionil L-Carnitina (GPLC): 1000-4000 mg

Some adults try a few doses to find what works best for them

Bismuth subsalicylate (Pepto-Bismol) may help reduce gastrointestinal odors through its antimicrobial properties and ability to bind some sulfur compounds

But it has a critical limitation that every natural GLP-1 supplement must contend with

In response, leading pharmas have announced massive capacity expansions: Novo Nordisk plans a $4.1 billion manufacturing facility in North Carolina ( [5] ) (opening ~2029), and Lilly has committed over $15 billion for new plants in Indiana, Wisconsin, Pennsylvania, and Alabama ( [6] ) ( [7] ) ( [8] ) ( [9] )